Unknown

Dataset Information

0

Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists.


ABSTRACT: UDP and UDP-glucose activate the P2Y14 receptor (P2Y14R) to modulate processes related to inflammation, diabetes, and asthma. A computational pipeline suggested alternatives to naphthalene of a previously reported P2Y14R antagonist (3, PPTN) using docking and molecular dynamics simulations on a hP2Y14R homology model based on P2Y12R structures. By reevaluating the binding of 3 to P2Y14R computationally, two alternatives, i.e., alkynyl and triazolyl derivatives, were identified. Improved synthesis of fluorescent antagonist 4 enabled affinity quantification (IC50s, nM) using flow cytometry of P2Y14R-expressing CHO cells. p-F3C-phenyl-triazole 65 (32) was more potent than a corresponding alkyne 11. Thus, additional triazolyl derivatives were prepared, as guided by docking simulations, with nonpolar aryl substituents favored. Although triazoles were less potent than 3 (6), simpler synthesis facilitated further structural optimization. Additionally, relative P2Y14R affinities agreed with predicted binding of alkynyl and triazole analogues. These triazoles, designed through a structure-based approach, can be assessed in disease models.

SUBMITTER: Junker A 

PROVIDER: S-EPMC4947982 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists.

Junker Anna A   Balasubramanian Ramachandran R   Ciancetta Antonella A   Uliassi Elisa E   Kiselev Evgeny E   Martiriggiano Chiara C   Trujillo Kevin K   Mtchedlidze Giorgi G   Birdwell Leah L   Brown Kyle A KA   Harden T Kendall TK   Jacobson Kenneth A KA  

Journal of medicinal chemistry 20160622 13


UDP and UDP-glucose activate the P2Y14 receptor (P2Y14R) to modulate processes related to inflammation, diabetes, and asthma. A computational pipeline suggested alternatives to naphthalene of a previously reported P2Y14R antagonist (3, PPTN) using docking and molecular dynamics simulations on a hP2Y14R homology model based on P2Y12R structures. By reevaluating the binding of 3 to P2Y14R computationally, two alternatives, i.e., alkynyl and triazolyl derivatives, were identified. Improved synthesi  ...[more]

Similar Datasets

| S-EPMC6651781 | biostudies-literature
| S-EPMC5000766 | biostudies-literature
| S-EPMC9786072 | biostudies-literature
| S-EPMC3515234 | biostudies-literature
| S-EPMC3515233 | biostudies-literature
| S-EPMC3247347 | biostudies-literature
| S-EPMC4011308 | biostudies-literature
| S-EPMC2962245 | biostudies-literature
| S-EPMC3238858 | biostudies-literature
| S-EPMC3884370 | biostudies-literature